An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools for Type 1 Diabetes Progression Morrisville, N.C.- based Metabolon, Inc., has received a grant from the National Institutes of Health (NIH) to develop an innovative product aimed at better monitoring...
Society Advocates for Protecting Access to IVF Treatment and PFAS Education at AMA Annual Meeting
In June, Endocrine Society members Salwa Zahalka, MD; Palak Choksi, MD; Mandy Bell, MD; and Dan Spratt, MD; who serve as the Society’s delegation to the American Medical Association’s (AMA) House of Delegates, attended the AMA meeting in Chicago to advocate for policies important to our members. The AMA House of Delegates meets twice a...
Remembering “Father of Tamoxifen,” V. Craig Jordan, OBE, DSc, PhD
Pharmacologist V. Craig Jordan, OBE, DSc, PhD, a 2018 recipient of the Endocrine Society’s Gerald D. Aurbach Award for Outstanding Translational Research, passed away at the age of 76. Jordan, a professor of Breast and Medical Oncology and Molecular and Cellular Oncology at The University of Texas MD Anderson Cancer Center, discovered selective estrogen receptor modulators... A conversation with Bruno Ferraz-de-Souza, MD, PhD, and Stephen M. Rosenthal, MD As part of Endocrine News LGBTQ+ Pride Month coverage, we caught up with Bruno Ferraz-de-Souza, MD, PhD, and Stephen M. Rosenthal, MD, who had a lot to say about being openly gay in the world of endocrinology, both in the U.S. and abroad,...
Full Circle: Q&A with New Endocrinology Editor-in-Chief, Zane Andrews, PhD
When Zane Andrews, PhD, published his very first scientific paper while working on his PhD in 2001, it was in the pages of the Endocrine Society’s Endocrinology. This month, he assumes his newest role as Endocrinology’s editor-in-chief. This month, Zane Andrews, PhD, of Monash University in Melbourne, Australia, will begin his tenure as editor-in-chief of...Meet New Endocrine Society President, John Newell-Price, MD, PhD
The Endocrine Society is pleased to welcome its president for 2024 – 2025, John Newell-Price, MD, PhD, FRCP, who took office during ENDO 2024 in Boston. Newell-Price is Professor of Endocrinology at the University of Sheffield, United Kingdom. He is also head of the Endocrinology Service at Sheffield Teaching Hospitals NHS Foundation Trust and of... Society Advocates for Access to Diabetes and Obesity Medications; Meets with FDA to Discuss Current Prescription Drug Shortages Over the past several months, the Endocrine Society has advocated for improving access to diabetes and obesity medications amid ongoing drug shortages that have impacted the country. The Society has heard from our members that they are...
Body Positive: A Closer Look at BMI Criteria for Gender-Affirming Surgery
Body mass index (BMI) requirements for gender-affirming surgeries can sometimes present an obstacle to gender transition surgery for many transgender and gender diverse people. Sean Iwamoto, MD, and John M. Taormina, MD, two of the authors of a recent Journal of Clinical Endocrinology & Metabolism paper, discuss the need for a multidisciplinary approach for these...
